(RTTNews) - McKesson (MCK) signed a definitive agreement to acquire a controlling interest in PRISM Vision Holdings, LLC, a provider of general ophthalmology and retina management services, from Quad-C. McKesson will purchase an 80% interest for approximately $850 million. PRISM Vision physicians will continue to retain a 20% interest in PRISM Vision. The company said PRISM Vision will be consolidated within U.S. Pharmaceutical segment.
McKesson said, upon closing, PRISM Vision is anticipated to be approximately $0.20 to $0.30 accretive to adjusted earnings per share in the first 12 months, and $0.65 to $0.75 accretive by the end of the third year following the close of the transaction.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
